Cargando…

Programmed cell death protein-1 (PD-1) protects liver damage by suppressing IFN-γ expression in T cells in infants and neonatal mice

BACKGROUND: Biliary atresia (BA) is a severe cholangiopathy possibly resulting from virus-induced and immune-mediated injury of the biliary system. IFN-γ, secreted from CD4(+) Th1 cells and CD8(+) cytotoxic T cells, is a major mediator of liver pathology. Programmed death protein-1 (PD-1) signaling...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Xuangjie, Xu, Yiping, Luo, Wei, Fang, Rongli, Cai, Li, Wang, Ping, Zhang, Yuxia, Wen, Zhe, Xu, Yanhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284022/
https://www.ncbi.nlm.nih.gov/pubmed/34271894
http://dx.doi.org/10.1186/s12887-021-02794-x
Descripción
Sumario:BACKGROUND: Biliary atresia (BA) is a severe cholangiopathy possibly resulting from virus-induced and immune-mediated injury of the biliary system. IFN-γ, secreted from CD4(+) Th1 cells and CD8(+) cytotoxic T cells, is a major mediator of liver pathology. Programmed death protein-1 (PD-1) signaling suppresses T cell function. However, how PD-1 modify T cell function in BA remains incompletely understood. METHODS: Frequencies of PD-1 expressing CD4(+) and CD8(+) T cells were analyzed in the liver and blood from BA and control subjects. Associations of PD-1(+)CD4(+)/CD8(+)T cell abundances with liver function indices were measured. Function of PD-1 was measured by administration of an anti-PD-1 antibody in a Rhesus Rotavirus (RRV)-induced BA model. Survival, histology, direct bilirubin, liver immune cell subsets and cytokine production were analyzed. RESULTS: PD-1 was significantly upregulated in CD4(+) and CD8(+) T cells in patients with BA compared with control subjects. PD-1 expression in T cells was negatively associated with IFN-γ concentration in liver (PD-1(+)CD4(+)T cells in liver vs. IFN-γ concentration, r = − 0.25, p = 0.05; PD-1(+)CD8(+)T cells in liver vs. IFN-γ concentration, r = − 0.39, p = 0.004). Blockade of PD-1 increased IFN-γ expression in CD4(+) T and CD8(+) T cells (RRV vs. anti-PD-1 treated RRV mice: 11.59 ± 3.43% vs. 21.26 ± 5.32% IFN-γ(+) in hepatic CD4(+)T cells, p = 0.0003; 9.33 ± 4.03% vs. 22.55 ± 7.47% IFN-γ(+) in hepatic CD8(+)T cells, p = 0.0001), suppressed bilirubin production (RRV vs. anti-PD-1 treated RRV mice: 285.4 ± 47.93 vs. 229.8 ± 45.86 μmol/L total bilirubin, p = 0.01) and exacerbated liver immunopathology. CONCLUSIONS: PD-1 plays a protective role in infants with BA by suppressing IFN-γ production in T cells. Increasing PD-1 signaling may serve as a therapeutic strategy for BA. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12887-021-02794-x.